2025-01-04 14:35:04,101 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:35:04,101 - INFO - Run 0:
To forecast whether the Secretary of the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox (monkeypox) before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of the situation.

### Step 1: Triage and Reference Relevant Predictions
I will first look for any existing predictions or base rates from platforms like Metaculus or FiveThirtyEight. However, since no specific predictions are provided, I will rely on historical patterns of PHE declarations and the current mpox situation.

### Step 2: Break the Problem into Sub-Problems
- **Historical Base Rate**: How often has HHS declared a PHE for infectious diseases in similar situations?
- **Current Situation**: What is the severity and spread of mpox in the US and globally?
- **Policy and Political Context**: What is the likelihood of HHS taking action based on the current political and public health climate?

### Step 3: Strike the Balance Between Inside and Outside Views
- **Outside View**: Historically, PHE declarations for infectious diseases are rare and typically occur when there is a significant threat to public health, such as widespread transmission or high mortality.
- **Inside View**: The current mpox outbreak is concentrated in Africa, with a new, more transmissible strain causing concern. However, the US has not seen a significant increase in cases, and the WHO has already declared a global health emergency.

### Step 4: Balance Under- and Overreacting to Evidence
- **Evidence for a Higher Estimate**: The WHO has declared mpox a global health emergency, which could pressure the US to take similar action. The new strain is more transmissible and has caused significant outbreaks in Africa.
- **Evidence for a Lower Estimate**: The US has not seen a significant increase in mpox cases, and the current strain is not spreading rapidly within the country. HHS may wait for more evidence before declaring a PHE.

### Step 5: Identify Clashing Causal Forces
- **Forces for Declaration**: International pressure, potential for global spread, and the need for coordinated response.
- **Forces Against Declaration**: Limited domestic cases, political reluctance to declare emergencies, and the availability of vaccines and treatments.

### Step 6: Extrapolate Current Trends Linearly
- The current trend shows a significant outbreak in Africa but limited spread in the US. Without a sudden increase in US cases, the trend does not strongly support a PHE declaration.

### Step 7: Distinguish Degrees of Doubt
- There is a moderate chance (30-40%) that HHS could declare a PHE if the situation worsens, but the current evidence does not strongly support this outcome.

### Step 8: Balance Under- and Overconfidence
- I will avoid overconfidence by acknowledging the uncertainty in the situation and the potential for rapid changes.

### Step 9: Learn from Errors
- I will consider the possibility of underestimating the risk of a sudden increase in cases or overestimating the political will to declare a PHE.

### Final Forecast
After balancing all the evidence, I conclude that the probability of HHS declaring a PHE for mpox before October 1, 2024, is relatively low, given the current situation.

**My Prediction: Between 20.00% and 40.00%, but 30.00% being the most likely. Probability: 30.00%.**

2025-01-04 14:35:20,374 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:35:20,374 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:35:20,389 - INFO - Run 1:
To forecast whether the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of the situation.

### Step 1: Triage and Reference Relevant Predictions
- **Base Rate Analysis**: Historically, the US has declared PHEs for infectious diseases like COVID-19, Ebola, and Zika. However, mpox (monkeypox) has not previously triggered a PHE declaration in the US, despite outbreaks in 2022. This suggests a lower base rate for such a declaration.
- **Current Context**: The WHO has declared mpox a global health emergency, and Africa CDC has declared it a continental emergency. This increases the likelihood of international pressure on the US to act, but it does not guarantee a PHE declaration.

### Step 2: Break the Problem into Sub-Problems
1. **Global and Domestic Spread**: The mpox outbreak is concentrated in Africa, with over 14,000 cases and 524 deaths reported in 2024. While cases in the US are minimal, the global spread and WHO declaration increase the risk of domestic spread.
2. **US Response**: The US has a robust public health infrastructure and has previously managed mpox outbreaks without declaring a PHE. However, the new, more transmissible strain in Africa could change this calculus.
3. **Political and Public Pressure**: The WHO declaration and media coverage may increase public and political pressure on HHS to act, but this is not guaranteed to result in a PHE declaration.

### Step 3: Balance Inside and Outside Views
- **Outside View**: Based on historical patterns, the likelihood of a PHE declaration for mpox is low, given the lack of precedent and the current limited domestic impact.
- **Inside View**: The new strain in Africa, WHO declaration, and potential for global spread increase the risk, but the US has not yet seen a significant domestic outbreak.

### Step 4: Balance Under- and Overreacting to Evidence
- **Strong Evidence for Lower Estimate**: The US has not declared a PHE for mpox in the past, and domestic cases remain low. The outbreak is primarily concentrated in Africa.
- **Strong Evidence for Higher Estimate**: The WHO declaration, new transmissible strain, and potential for global spread increase the risk of a domestic outbreak, which could prompt a PHE declaration.

### Step 5: Clashing Causal Forces
- **Forces for a PHE Declaration**: International pressure, new transmissible strain, potential for domestic spread.
- **Forces Against a PHE Declaration**: Low domestic cases, historical lack of PHE declarations for mpox, robust US public health infrastructure.

### Step 6: Extrapolate Current Trends
- The current trend shows a significant outbreak in Africa but limited domestic impact in the US. Without a significant increase in domestic cases, a PHE declaration is unlikely.

### Step 7: Degrees of Doubt
- There is uncertainty about the potential for domestic spread and the political will to declare a PHE. However, the current evidence suggests a low likelihood.

### Step 8: Balance Under- and Overconfidence
- While there is some risk of a PHE declaration, the evidence does not strongly support it. Overconfidence in a low probability is justified given the current data.

### Step 9: Errors Behind Mistakes
- Potential errors include underestimating the speed of domestic spread or overestimating the political will to declare a PHE. However, these risks are mitigated by the current low domestic impact.

### Final Forecast
Considering the historical lack of PHE declarations for mpox, the current low domestic impact, and the robust US public health infrastructure, the likelihood of a PHE declaration before October 1, 2024, is low. However, the WHO declaration and new strain introduce some risk.

**My Prediction: Between 10.00% and 25.00%, but 15.00% being the most likely. Probability: 15.00%.**

2025-01-04 14:35:20,389 - INFO - Run 1:
To forecast whether the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of the situation.

### Step 1: Triage and Reference Relevant Predictions
- **Base Rate Analysis**: Historically, the US has declared PHEs for infectious diseases like COVID-19, Ebola, and Zika. However, mpox (monkeypox) has not previously triggered a PHE declaration in the US, despite outbreaks in 2022. This suggests a lower base rate for such a declaration.
- **Current Context**: The WHO has declared mpox a global health emergency, and Africa CDC has declared it a continental emergency. This increases the likelihood of international pressure on the US to act, but it does not guarantee a PHE declaration.

### Step 2: Break the Problem into Sub-Problems
1. **Global and Domestic Spread**: The mpox outbreak is concentrated in Africa, with over 14,000 cases and 524 deaths reported in 2024. While cases in the US are minimal, the global spread and WHO declaration increase the risk of domestic spread.
2. **US Response**: The US has a robust public health infrastructure and has previously managed mpox outbreaks without declaring a PHE. However, the new, more transmissible strain in Africa could change this calculus.
3. **Political and Public Pressure**: The WHO declaration and media coverage may increase public and political pressure on HHS to act, but this is not guaranteed to result in a PHE declaration.

### Step 3: Balance Inside and Outside Views
- **Outside View**: Based on historical patterns, the likelihood of a PHE declaration for mpox is low, given the lack of precedent and the current limited domestic impact.
- **Inside View**: The new strain in Africa, WHO declaration, and potential for global spread increase the risk, but the US has not yet seen a significant domestic outbreak.

### Step 4: Balance Under- and Overreacting to Evidence
- **Strong Evidence for Lower Estimate**: The US has not declared a PHE for mpox in the past, and domestic cases remain low. The outbreak is primarily concentrated in Africa.
- **Strong Evidence for Higher Estimate**: The WHO declaration, new transmissible strain, and potential for global spread increase the risk of a domestic outbreak, which could prompt a PHE declaration.

### Step 5: Clashing Causal Forces
- **Forces for a PHE Declaration**: International pressure, new transmissible strain, potential for domestic spread.
- **Forces Against a PHE Declaration**: Low domestic cases, historical lack of PHE declarations for mpox, robust US public health infrastructure.

### Step 6: Extrapolate Current Trends
- The current trend shows a significant outbreak in Africa but limited domestic impact in the US. Without a significant increase in domestic cases, a PHE declaration is unlikely.

### Step 7: Degrees of Doubt
- There is uncertainty about the potential for domestic spread and the political will to declare a PHE. However, the current evidence suggests a low likelihood.

### Step 8: Balance Under- and Overconfidence
- While there is some risk of a PHE declaration, the evidence does not strongly support it. Overconfidence in a low probability is justified given the current data.

### Step 9: Errors Behind Mistakes
- Potential errors include underestimating the speed of domestic spread or overestimating the political will to declare a PHE. However, these risks are mitigated by the current low domestic impact.

### Final Forecast
Considering the historical lack of PHE declarations for mpox, the current low domestic impact, and the robust US public health infrastructure, the likelihood of a PHE declaration before October 1, 2024, is low. However, the WHO declaration and new strain introduce some risk.

**My Prediction: Between 10.00% and 25.00%, but 15.00% being the most likely. Probability: 15.00%.**

2025-01-04 14:35:38,228 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:35:38,228 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:35:38,228 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:35:38,228 - INFO - Run 2:
To forecast whether the Secretary of the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox (monkeypox) before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of this situation.

### Step 1: Reference Relevant Predictions and Base Rates
- **Base Rate for PHE Declarations**: Historically, PHE declarations are rare and typically occur in response to significant, widespread threats to public health. The US has declared PHEs for diseases like COVID-19, Ebola, and Zika, but these were in response to outbreaks with high transmission rates, severe health impacts, and potential for rapid spread.
- **Mpox Context**: The WHO has declared mpox a global health emergency, and the Africa CDC has declared it a continental emergency. However, the US has not yet declared a PHE for mpox, despite the global situation. The 2022 mpox outbreak in the US led to significant public health measures but did not result in a PHE declaration.

### Step 2: Break the Problem into Sub-Problems
1. **Current Severity of Mpox in the US**: As of August 15, 2024, there is no evidence of a significant mpox outbreak in the US. The focus of the outbreak is primarily in Africa, with limited cases reported in Europe and other regions.
2. **Potential for Spread to the US**: The new, more transmissible strain (Clade Ib) is concerning, but there is no evidence yet of widespread transmission outside Africa. The US has robust public health infrastructure to detect and contain outbreaks.
3. **HHS Decision-Making Process**: HHS typically declares a PHE when there is a clear and present danger to public health within the US. Given the current lack of significant cases in the US, the likelihood of a PHE declaration is low.

### Step 3: Balance Inside and Outside Views
- **Outside View**: Based on historical patterns, PHE declarations are rare and require clear evidence of a significant threat within the US. The current mpox situation does not meet this threshold.
- **Inside View**: The WHO and Africa CDC declarations indicate a serious global situation, but the US has not yet seen a comparable threat. The US response to the 2022 mpox outbreak suggests that a PHE declaration is unlikely unless there is a significant increase in cases.

### Step 4: Adjust for Current Evidence
- **Global Situation**: The WHO declaration and the Africa CDC emergency declaration highlight the severity of the outbreak in Africa. However, these do not directly translate to a US PHE declaration unless the outbreak spreads significantly to the US.
- **US Situation**: There is no evidence of a significant mpox outbreak in the US as of August 15, 2024. The US has not declared a PHE for mpox despite the global situation.

### Step 5: Clashing Causal Forces
- **For a PHE Declaration**: The global emergency declarations by the WHO and Africa CDC could pressure the US to take similar action, especially if cases begin to rise in the US.
- **Against a PHE Declaration**: The lack of significant cases in the US and the robust public health infrastructure reduce the likelihood of a PHE declaration.

### Step 6: Extrapolate Current Trends
- The current trend shows that mpox is primarily an African issue, with limited spread to other regions. Unless there is a significant change in the US, the likelihood of a PHE declaration remains low.

### Step 7: Degrees of Doubt
- There is a small chance that the situation could escalate in the US, but this is not supported by current evidence. The most likely scenario is that the US will not declare a PHE for mpox before October 1, 2024.

### Step 8: Balance Under- and Overconfidence
- While the global situation is serious, the lack of significant cases in the US makes a PHE declaration unlikely. However, there is always a small chance of unexpected developments.

### Step 9: Learn from Past Mistakes
- Overreacting to global declarations without considering local context can lead to errors. The US response to the 2022 mpox outbreak provides a useful reference point.

### Final Forecast
Based on the above analysis, the most likely outcome is that the US will not declare a PHE for mpox before October 1, 2024. However, there is a small chance that the situation could change.

**My Prediction: Between 5.00% and 15.00%, but 10.00% being the most likely. Probability: 10.00%.**

2025-01-04 14:35:38,228 - INFO - Run 2:
To forecast whether the Secretary of the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox (monkeypox) before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of this situation.

### Step 1: Reference Relevant Predictions and Base Rates
- **Base Rate for PHE Declarations**: Historically, PHE declarations are rare and typically occur in response to significant, widespread threats to public health. The US has declared PHEs for diseases like COVID-19, Ebola, and Zika, but these were in response to outbreaks with high transmission rates, severe health impacts, and potential for rapid spread.
- **Mpox Context**: The WHO has declared mpox a global health emergency, and the Africa CDC has declared it a continental emergency. However, the US has not yet declared a PHE for mpox, despite the global situation. The 2022 mpox outbreak in the US led to significant public health measures but did not result in a PHE declaration.

### Step 2: Break the Problem into Sub-Problems
1. **Current Severity of Mpox in the US**: As of August 15, 2024, there is no evidence of a significant mpox outbreak in the US. The focus of the outbreak is primarily in Africa, with limited cases reported in Europe and other regions.
2. **Potential for Spread to the US**: The new, more transmissible strain (Clade Ib) is concerning, but there is no evidence yet of widespread transmission outside Africa. The US has robust public health infrastructure to detect and contain outbreaks.
3. **HHS Decision-Making Process**: HHS typically declares a PHE when there is a clear and present danger to public health within the US. Given the current lack of significant cases in the US, the likelihood of a PHE declaration is low.

### Step 3: Balance Inside and Outside Views
- **Outside View**: Based on historical patterns, PHE declarations are rare and require clear evidence of a significant threat within the US. The current mpox situation does not meet this threshold.
- **Inside View**: The WHO and Africa CDC declarations indicate a serious global situation, but the US has not yet seen a comparable threat. The US response to the 2022 mpox outbreak suggests that a PHE declaration is unlikely unless there is a significant increase in cases.

### Step 4: Adjust for Current Evidence
- **Global Situation**: The WHO declaration and the Africa CDC emergency declaration highlight the severity of the outbreak in Africa. However, these do not directly translate to a US PHE declaration unless the outbreak spreads significantly to the US.
- **US Situation**: There is no evidence of a significant mpox outbreak in the US as of August 15, 2024. The US has not declared a PHE for mpox despite the global situation.

### Step 5: Clashing Causal Forces
- **For a PHE Declaration**: The global emergency declarations by the WHO and Africa CDC could pressure the US to take similar action, especially if cases begin to rise in the US.
- **Against a PHE Declaration**: The lack of significant cases in the US and the robust public health infrastructure reduce the likelihood of a PHE declaration.

### Step 6: Extrapolate Current Trends
- The current trend shows that mpox is primarily an African issue, with limited spread to other regions. Unless there is a significant change in the US, the likelihood of a PHE declaration remains low.

### Step 7: Degrees of Doubt
- There is a small chance that the situation could escalate in the US, but this is not supported by current evidence. The most likely scenario is that the US will not declare a PHE for mpox before October 1, 2024.

### Step 8: Balance Under- and Overconfidence
- While the global situation is serious, the lack of significant cases in the US makes a PHE declaration unlikely. However, there is always a small chance of unexpected developments.

### Step 9: Learn from Past Mistakes
- Overreacting to global declarations without considering local context can lead to errors. The US response to the 2022 mpox outbreak provides a useful reference point.

### Final Forecast
Based on the above analysis, the most likely outcome is that the US will not declare a PHE for mpox before October 1, 2024. However, there is a small chance that the situation could change.

**My Prediction: Between 5.00% and 15.00%, but 10.00% being the most likely. Probability: 10.00%.**

2025-01-04 14:35:38,228 - INFO - Run 2:
To forecast whether the Secretary of the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox (monkeypox) before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of this situation.

### Step 1: Reference Relevant Predictions and Base Rates
- **Base Rate for PHE Declarations**: Historically, PHE declarations are rare and typically occur in response to significant, widespread threats to public health. The US has declared PHEs for diseases like COVID-19, Ebola, and Zika, but these were in response to outbreaks with high transmission rates, severe health impacts, and potential for rapid spread.
- **Mpox Context**: The WHO has declared mpox a global health emergency, and the Africa CDC has declared it a continental emergency. However, the US has not yet declared a PHE for mpox, despite the global situation. The 2022 mpox outbreak in the US led to significant public health measures but did not result in a PHE declaration.

### Step 2: Break the Problem into Sub-Problems
1. **Current Severity of Mpox in the US**: As of August 15, 2024, there is no evidence of a significant mpox outbreak in the US. The focus of the outbreak is primarily in Africa, with limited cases reported in Europe and other regions.
2. **Potential for Spread to the US**: The new, more transmissible strain (Clade Ib) is concerning, but there is no evidence yet of widespread transmission outside Africa. The US has robust public health infrastructure to detect and contain outbreaks.
3. **HHS Decision-Making Process**: HHS typically declares a PHE when there is a clear and present danger to public health within the US. Given the current lack of significant cases in the US, the likelihood of a PHE declaration is low.

### Step 3: Balance Inside and Outside Views
- **Outside View**: Based on historical patterns, PHE declarations are rare and require clear evidence of a significant threat within the US. The current mpox situation does not meet this threshold.
- **Inside View**: The WHO and Africa CDC declarations indicate a serious global situation, but the US has not yet seen a comparable threat. The US response to the 2022 mpox outbreak suggests that a PHE declaration is unlikely unless there is a significant increase in cases.

### Step 4: Adjust for Current Evidence
- **Global Situation**: The WHO declaration and the Africa CDC emergency declaration highlight the severity of the outbreak in Africa. However, these do not directly translate to a US PHE declaration unless the outbreak spreads significantly to the US.
- **US Situation**: There is no evidence of a significant mpox outbreak in the US as of August 15, 2024. The US has not declared a PHE for mpox despite the global situation.

### Step 5: Clashing Causal Forces
- **For a PHE Declaration**: The global emergency declarations by the WHO and Africa CDC could pressure the US to take similar action, especially if cases begin to rise in the US.
- **Against a PHE Declaration**: The lack of significant cases in the US and the robust public health infrastructure reduce the likelihood of a PHE declaration.

### Step 6: Extrapolate Current Trends
- The current trend shows that mpox is primarily an African issue, with limited spread to other regions. Unless there is a significant change in the US, the likelihood of a PHE declaration remains low.

### Step 7: Degrees of Doubt
- There is a small chance that the situation could escalate in the US, but this is not supported by current evidence. The most likely scenario is that the US will not declare a PHE for mpox before October 1, 2024.

### Step 8: Balance Under- and Overconfidence
- While the global situation is serious, the lack of significant cases in the US makes a PHE declaration unlikely. However, there is always a small chance of unexpected developments.

### Step 9: Learn from Past Mistakes
- Overreacting to global declarations without considering local context can lead to errors. The US response to the 2022 mpox outbreak provides a useful reference point.

### Final Forecast
Based on the above analysis, the most likely outcome is that the US will not declare a PHE for mpox before October 1, 2024. However, there is a small chance that the situation could change.

**My Prediction: Between 5.00% and 15.00%, but 10.00% being the most likely. Probability: 10.00%.**

2025-01-04 14:35:44,247 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:35:44,247 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:35:44,247 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:35:44,247 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:35:44,247 - INFO - Run 3:
My Prediction: Between 25.00% and 40.00%, but 32.50% being the most likely. Probability: 32.50%.

2025-01-04 14:35:44,247 - INFO - Run 3:
My Prediction: Between 25.00% and 40.00%, but 32.50% being the most likely. Probability: 32.50%.

2025-01-04 14:35:44,247 - INFO - Run 3:
My Prediction: Between 25.00% and 40.00%, but 32.50% being the most likely. Probability: 32.50%.

2025-01-04 14:35:44,247 - INFO - Run 3:
My Prediction: Between 25.00% and 40.00%, but 32.50% being the most likely. Probability: 32.50%.

2025-01-04 14:36:02,163 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:36:02,163 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:36:02,163 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:36:02,163 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:36:02,163 - INFO - Question: Will the Secretary of the US Department of Health and Human Services declare a public health emergency for mpox (monkeypox) before October 1, 2024?
2025-01-04 14:36:02,163 - INFO - Run 4:
To forecast whether the Secretary of the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox (monkeypox) before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of this situation.

### Step 1: Triage and Reference Relevant Predictions
- **Base Rates**: Historically, the US has declared PHEs for infectious diseases like COVID-19, Ebola, and Zika. However, mpox (monkeypox) has not previously triggered a PHE declaration in the US, despite outbreaks in 2022. This suggests a lower base rate for such a declaration.
- **Current Predictions**: As of now, there are no widely available predictions from platforms like FiveThirtyEight, Polymarket, or Metaculus specifically addressing this question. This lack of data means I must rely more heavily on the available evidence and historical context.

### Step 2: Break the Problem into Sub-Problems
1. **Global Situation**: The WHO has declared mpox a global health emergency, with significant outbreaks in Africa, particularly in the Democratic Republic of Congo (DRC). This increases the likelihood of international pressure on the US to act.
2. **US Situation**: The US has experienced mpox outbreaks in the past, particularly in 2022, but did not declare a PHE. Current data shows limited cases in the US, with no significant increase in transmission or severity.
3. **HHS Decision-Making**: The HHS typically declares a PHE when there is a significant threat to public health, requiring federal coordination and resources. The decision is influenced by factors like case numbers, transmission rates, and potential for spread.

### Step 3: Balance Inside and Outside Views
- **Outside View**: Based on historical patterns, the US is less likely to declare a PHE for mpox unless there is a significant increase in cases or severity.
- **Inside View**: The current global situation, with the WHO declaring a global emergency and the spread of a more transmissible variant, could increase the likelihood of a US declaration, especially if cases rise domestically.

### Step 4: Balance Under- and Overreacting to Evidence
- **Evidence for a Declaration**: The WHO's declaration, the spread of a more transmissible variant, and the potential for international spread could pressure the US to act preemptively.
- **Evidence Against a Declaration**: The US has not seen a significant increase in cases, and the 2022 outbreak did not result in a PHE declaration. The current situation may not meet the threshold for a federal emergency.

### Step 5: Clashing Causal Forces
- **Forces for Declaration**: International pressure, potential for global spread, and the need for coordinated response.
- **Forces Against Declaration**: Low case numbers in the US, lack of immediate threat, and historical reluctance to declare PHEs for mpox.

### Step 6: Extrapolate Current Trends
- **Global Trends**: Cases are increasing in Africa, but there is no clear evidence of rapid spread to the US.
- **US Trends**: Cases remain low, with no significant upward trend.

### Step 7: Degrees of Doubt
- **High Uncertainty**: The global situation is dynamic, and the US could see an increase in cases, especially with international travel.
- **Low Uncertainty**: The US has not historically declared PHEs for mpox, and current case numbers do not suggest an immediate need.

### Step 8: Balance Under- and Overconfidence
- **Prudence**: Given the uncertainty, it is prudent to assign a moderate probability, acknowledging both the potential for a declaration and the lack of immediate need.
- **Decisiveness**: The most likely scenario is that the US will not declare a PHE unless there is a significant change in the domestic situation.

### Step 9: Learn from Errors
- **Potential Errors**: Overestimating the likelihood of a declaration based on global trends without considering domestic factors, or underestimating the potential for a rapid increase in cases.

### Final Forecast
Balancing all these factors, I estimate that the probability of the HHS declaring a PHE for mpox before October 1, 2024, is relatively low, given the current domestic situation and historical patterns. However, the global context and potential for increased cases introduce some uncertainty.

**My Prediction: Between 15.00% and 30.00%, but 20.00% being the most likely. Probability: 20.00%.**

2025-01-04 14:36:02,163 - INFO - Run 4:
To forecast whether the Secretary of the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox (monkeypox) before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of this situation.

### Step 1: Triage and Reference Relevant Predictions
- **Base Rates**: Historically, the US has declared PHEs for infectious diseases like COVID-19, Ebola, and Zika. However, mpox (monkeypox) has not previously triggered a PHE declaration in the US, despite outbreaks in 2022. This suggests a lower base rate for such a declaration.
- **Current Predictions**: As of now, there are no widely available predictions from platforms like FiveThirtyEight, Polymarket, or Metaculus specifically addressing this question. This lack of data means I must rely more heavily on the available evidence and historical context.

### Step 2: Break the Problem into Sub-Problems
1. **Global Situation**: The WHO has declared mpox a global health emergency, with significant outbreaks in Africa, particularly in the Democratic Republic of Congo (DRC). This increases the likelihood of international pressure on the US to act.
2. **US Situation**: The US has experienced mpox outbreaks in the past, particularly in 2022, but did not declare a PHE. Current data shows limited cases in the US, with no significant increase in transmission or severity.
3. **HHS Decision-Making**: The HHS typically declares a PHE when there is a significant threat to public health, requiring federal coordination and resources. The decision is influenced by factors like case numbers, transmission rates, and potential for spread.

### Step 3: Balance Inside and Outside Views
- **Outside View**: Based on historical patterns, the US is less likely to declare a PHE for mpox unless there is a significant increase in cases or severity.
- **Inside View**: The current global situation, with the WHO declaring a global emergency and the spread of a more transmissible variant, could increase the likelihood of a US declaration, especially if cases rise domestically.

### Step 4: Balance Under- and Overreacting to Evidence
- **Evidence for a Declaration**: The WHO's declaration, the spread of a more transmissible variant, and the potential for international spread could pressure the US to act preemptively.
- **Evidence Against a Declaration**: The US has not seen a significant increase in cases, and the 2022 outbreak did not result in a PHE declaration. The current situation may not meet the threshold for a federal emergency.

### Step 5: Clashing Causal Forces
- **Forces for Declaration**: International pressure, potential for global spread, and the need for coordinated response.
- **Forces Against Declaration**: Low case numbers in the US, lack of immediate threat, and historical reluctance to declare PHEs for mpox.

### Step 6: Extrapolate Current Trends
- **Global Trends**: Cases are increasing in Africa, but there is no clear evidence of rapid spread to the US.
- **US Trends**: Cases remain low, with no significant upward trend.

### Step 7: Degrees of Doubt
- **High Uncertainty**: The global situation is dynamic, and the US could see an increase in cases, especially with international travel.
- **Low Uncertainty**: The US has not historically declared PHEs for mpox, and current case numbers do not suggest an immediate need.

### Step 8: Balance Under- and Overconfidence
- **Prudence**: Given the uncertainty, it is prudent to assign a moderate probability, acknowledging both the potential for a declaration and the lack of immediate need.
- **Decisiveness**: The most likely scenario is that the US will not declare a PHE unless there is a significant change in the domestic situation.

### Step 9: Learn from Errors
- **Potential Errors**: Overestimating the likelihood of a declaration based on global trends without considering domestic factors, or underestimating the potential for a rapid increase in cases.

### Final Forecast
Balancing all these factors, I estimate that the probability of the HHS declaring a PHE for mpox before October 1, 2024, is relatively low, given the current domestic situation and historical patterns. However, the global context and potential for increased cases introduce some uncertainty.

**My Prediction: Between 15.00% and 30.00%, but 20.00% being the most likely. Probability: 20.00%.**

2025-01-04 14:36:02,163 - INFO - Run 4:
To forecast whether the Secretary of the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox (monkeypox) before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of this situation.

### Step 1: Triage and Reference Relevant Predictions
- **Base Rates**: Historically, the US has declared PHEs for infectious diseases like COVID-19, Ebola, and Zika. However, mpox (monkeypox) has not previously triggered a PHE declaration in the US, despite outbreaks in 2022. This suggests a lower base rate for such a declaration.
- **Current Predictions**: As of now, there are no widely available predictions from platforms like FiveThirtyEight, Polymarket, or Metaculus specifically addressing this question. This lack of data means I must rely more heavily on the available evidence and historical context.

### Step 2: Break the Problem into Sub-Problems
1. **Global Situation**: The WHO has declared mpox a global health emergency, with significant outbreaks in Africa, particularly in the Democratic Republic of Congo (DRC). This increases the likelihood of international pressure on the US to act.
2. **US Situation**: The US has experienced mpox outbreaks in the past, particularly in 2022, but did not declare a PHE. Current data shows limited cases in the US, with no significant increase in transmission or severity.
3. **HHS Decision-Making**: The HHS typically declares a PHE when there is a significant threat to public health, requiring federal coordination and resources. The decision is influenced by factors like case numbers, transmission rates, and potential for spread.

### Step 3: Balance Inside and Outside Views
- **Outside View**: Based on historical patterns, the US is less likely to declare a PHE for mpox unless there is a significant increase in cases or severity.
- **Inside View**: The current global situation, with the WHO declaring a global emergency and the spread of a more transmissible variant, could increase the likelihood of a US declaration, especially if cases rise domestically.

### Step 4: Balance Under- and Overreacting to Evidence
- **Evidence for a Declaration**: The WHO's declaration, the spread of a more transmissible variant, and the potential for international spread could pressure the US to act preemptively.
- **Evidence Against a Declaration**: The US has not seen a significant increase in cases, and the 2022 outbreak did not result in a PHE declaration. The current situation may not meet the threshold for a federal emergency.

### Step 5: Clashing Causal Forces
- **Forces for Declaration**: International pressure, potential for global spread, and the need for coordinated response.
- **Forces Against Declaration**: Low case numbers in the US, lack of immediate threat, and historical reluctance to declare PHEs for mpox.

### Step 6: Extrapolate Current Trends
- **Global Trends**: Cases are increasing in Africa, but there is no clear evidence of rapid spread to the US.
- **US Trends**: Cases remain low, with no significant upward trend.

### Step 7: Degrees of Doubt
- **High Uncertainty**: The global situation is dynamic, and the US could see an increase in cases, especially with international travel.
- **Low Uncertainty**: The US has not historically declared PHEs for mpox, and current case numbers do not suggest an immediate need.

### Step 8: Balance Under- and Overconfidence
- **Prudence**: Given the uncertainty, it is prudent to assign a moderate probability, acknowledging both the potential for a declaration and the lack of immediate need.
- **Decisiveness**: The most likely scenario is that the US will not declare a PHE unless there is a significant change in the domestic situation.

### Step 9: Learn from Errors
- **Potential Errors**: Overestimating the likelihood of a declaration based on global trends without considering domestic factors, or underestimating the potential for a rapid increase in cases.

### Final Forecast
Balancing all these factors, I estimate that the probability of the HHS declaring a PHE for mpox before October 1, 2024, is relatively low, given the current domestic situation and historical patterns. However, the global context and potential for increased cases introduce some uncertainty.

**My Prediction: Between 15.00% and 30.00%, but 20.00% being the most likely. Probability: 20.00%.**

2025-01-04 14:36:02,163 - INFO - Run 4:
To forecast whether the Secretary of the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox (monkeypox) before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of this situation.

### Step 1: Triage and Reference Relevant Predictions
- **Base Rates**: Historically, the US has declared PHEs for infectious diseases like COVID-19, Ebola, and Zika. However, mpox (monkeypox) has not previously triggered a PHE declaration in the US, despite outbreaks in 2022. This suggests a lower base rate for such a declaration.
- **Current Predictions**: As of now, there are no widely available predictions from platforms like FiveThirtyEight, Polymarket, or Metaculus specifically addressing this question. This lack of data means I must rely more heavily on the available evidence and historical context.

### Step 2: Break the Problem into Sub-Problems
1. **Global Situation**: The WHO has declared mpox a global health emergency, with significant outbreaks in Africa, particularly in the Democratic Republic of Congo (DRC). This increases the likelihood of international pressure on the US to act.
2. **US Situation**: The US has experienced mpox outbreaks in the past, particularly in 2022, but did not declare a PHE. Current data shows limited cases in the US, with no significant increase in transmission or severity.
3. **HHS Decision-Making**: The HHS typically declares a PHE when there is a significant threat to public health, requiring federal coordination and resources. The decision is influenced by factors like case numbers, transmission rates, and potential for spread.

### Step 3: Balance Inside and Outside Views
- **Outside View**: Based on historical patterns, the US is less likely to declare a PHE for mpox unless there is a significant increase in cases or severity.
- **Inside View**: The current global situation, with the WHO declaring a global emergency and the spread of a more transmissible variant, could increase the likelihood of a US declaration, especially if cases rise domestically.

### Step 4: Balance Under- and Overreacting to Evidence
- **Evidence for a Declaration**: The WHO's declaration, the spread of a more transmissible variant, and the potential for international spread could pressure the US to act preemptively.
- **Evidence Against a Declaration**: The US has not seen a significant increase in cases, and the 2022 outbreak did not result in a PHE declaration. The current situation may not meet the threshold for a federal emergency.

### Step 5: Clashing Causal Forces
- **Forces for Declaration**: International pressure, potential for global spread, and the need for coordinated response.
- **Forces Against Declaration**: Low case numbers in the US, lack of immediate threat, and historical reluctance to declare PHEs for mpox.

### Step 6: Extrapolate Current Trends
- **Global Trends**: Cases are increasing in Africa, but there is no clear evidence of rapid spread to the US.
- **US Trends**: Cases remain low, with no significant upward trend.

### Step 7: Degrees of Doubt
- **High Uncertainty**: The global situation is dynamic, and the US could see an increase in cases, especially with international travel.
- **Low Uncertainty**: The US has not historically declared PHEs for mpox, and current case numbers do not suggest an immediate need.

### Step 8: Balance Under- and Overconfidence
- **Prudence**: Given the uncertainty, it is prudent to assign a moderate probability, acknowledging both the potential for a declaration and the lack of immediate need.
- **Decisiveness**: The most likely scenario is that the US will not declare a PHE unless there is a significant change in the domestic situation.

### Step 9: Learn from Errors
- **Potential Errors**: Overestimating the likelihood of a declaration based on global trends without considering domestic factors, or underestimating the potential for a rapid increase in cases.

### Final Forecast
Balancing all these factors, I estimate that the probability of the HHS declaring a PHE for mpox before October 1, 2024, is relatively low, given the current domestic situation and historical patterns. However, the global context and potential for increased cases introduce some uncertainty.

**My Prediction: Between 15.00% and 30.00%, but 20.00% being the most likely. Probability: 20.00%.**

2025-01-04 14:36:02,163 - INFO - Run 4:
To forecast whether the Secretary of the US Department of Health and Human Services (HHS) will declare a public health emergency (PHE) for mpox (monkeypox) before October 1, 2024, I will follow a structured approach, balancing historical patterns, current evidence, and the unique features of this situation.

### Step 1: Triage and Reference Relevant Predictions
- **Base Rates**: Historically, the US has declared PHEs for infectious diseases like COVID-19, Ebola, and Zika. However, mpox (monkeypox) has not previously triggered a PHE declaration in the US, despite outbreaks in 2022. This suggests a lower base rate for such a declaration.
- **Current Predictions**: As of now, there are no widely available predictions from platforms like FiveThirtyEight, Polymarket, or Metaculus specifically addressing this question. This lack of data means I must rely more heavily on the available evidence and historical context.

### Step 2: Break the Problem into Sub-Problems
1. **Global Situation**: The WHO has declared mpox a global health emergency, with significant outbreaks in Africa, particularly in the Democratic Republic of Congo (DRC). This increases the likelihood of international pressure on the US to act.
2. **US Situation**: The US has experienced mpox outbreaks in the past, particularly in 2022, but did not declare a PHE. Current data shows limited cases in the US, with no significant increase in transmission or severity.
3. **HHS Decision-Making**: The HHS typically declares a PHE when there is a significant threat to public health, requiring federal coordination and resources. The decision is influenced by factors like case numbers, transmission rates, and potential for spread.

### Step 3: Balance Inside and Outside Views
- **Outside View**: Based on historical patterns, the US is less likely to declare a PHE for mpox unless there is a significant increase in cases or severity.
- **Inside View**: The current global situation, with the WHO declaring a global emergency and the spread of a more transmissible variant, could increase the likelihood of a US declaration, especially if cases rise domestically.

### Step 4: Balance Under- and Overreacting to Evidence
- **Evidence for a Declaration**: The WHO's declaration, the spread of a more transmissible variant, and the potential for international spread could pressure the US to act preemptively.
- **Evidence Against a Declaration**: The US has not seen a significant increase in cases, and the 2022 outbreak did not result in a PHE declaration. The current situation may not meet the threshold for a federal emergency.

### Step 5: Clashing Causal Forces
- **Forces for Declaration**: International pressure, potential for global spread, and the need for coordinated response.
- **Forces Against Declaration**: Low case numbers in the US, lack of immediate threat, and historical reluctance to declare PHEs for mpox.

### Step 6: Extrapolate Current Trends
- **Global Trends**: Cases are increasing in Africa, but there is no clear evidence of rapid spread to the US.
- **US Trends**: Cases remain low, with no significant upward trend.

### Step 7: Degrees of Doubt
- **High Uncertainty**: The global situation is dynamic, and the US could see an increase in cases, especially with international travel.
- **Low Uncertainty**: The US has not historically declared PHEs for mpox, and current case numbers do not suggest an immediate need.

### Step 8: Balance Under- and Overconfidence
- **Prudence**: Given the uncertainty, it is prudent to assign a moderate probability, acknowledging both the potential for a declaration and the lack of immediate need.
- **Decisiveness**: The most likely scenario is that the US will not declare a PHE unless there is a significant change in the domestic situation.

### Step 9: Learn from Errors
- **Potential Errors**: Overestimating the likelihood of a declaration based on global trends without considering domestic factors, or underestimating the potential for a rapid increase in cases.

### Final Forecast
Balancing all these factors, I estimate that the probability of the HHS declaring a PHE for mpox before October 1, 2024, is relatively low, given the current domestic situation and historical patterns. However, the global context and potential for increased cases introduce some uncertainty.

**My Prediction: Between 15.00% and 30.00%, but 20.00% being the most likely. Probability: 20.00%.**

